Echocardiographic changes in patients with stage 3-5 chronic kidney disease and left ventricular diastolic

Leszek Gromadziński1, Piotr Pruszczyk2

  • 1Department of Internal Diseases, Gastroenterology and Hepatology, University Clinical Hospital in Olsztyn, Olsztyn, Poland ; Department of Internal Diseases, Gastroenterology, Cardiology and Infectiology, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.

Cardiorenal Medicine
|March 5, 2015
PubMed

Insights

Reduced mitral annular plane systolic excursion (MAPSE) is an independent predictor of left ventricular (LV) diastolic dysfunction in chronic kidney disease (CKD) patients. This finding aids in diagnosing heart failure in CKD individuals.

Area of Science:

  • Cardiology
  • Nephrology
  • Echocardiography

Background:

  • Left ventricular (LV) diastolic dysfunction is a common complication in chronic kidney disease (CKD) patients, often leading to congestive heart failure.
  • Early detection and management of LV diastolic dysfunction are crucial for improving outcomes in CKD patients.

Purpose of the Study:

  • To evaluate echocardiographic parameters in CKD patients with and without LV diastolic dysfunction.
  • To identify independent predictors of LV diastolic dysfunction in CKD.

Main Methods:

  • Seventy ambulatory CKD patients (stages 3-5) and 26 controls underwent standard echocardiography and tissue Doppler imaging.
  • Patients were categorized into diastolic dysfunction (DD) and without diastolic dysfunction (WDD) groups based on lateral mitral early diastolic velocity (EmLVlat).

Main Results:

  • Patients in the DD group exhibited significantly lower mitral annular plane systolic excursion (MAPSE) and lateral mitral annular systolic velocity (SmLVlat) compared to the WDD group.
  • MAPSE demonstrated high diagnostic accuracy (Area Under Curve = 0.801) for LV diastolic dysfunction, with a threshold of ≤13 mm showing 84.4% sensitivity and 75.8% specificity.
  • Reduced MAPSE was identified as the sole independent predictor of LV diastolic dysfunction in CKD patients (OR = 0.39).

Conclusions:

  • Reduced MAPSE is a significant independent predictive factor for LV diastolic dysfunction in CKD patients.
  • SmLVlat was not found to be an independent predictor in this cohort.
  • MAPSE serves as a valuable echocardiographic marker for assessing diastolic function in CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
667
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
627
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
651
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K